CRONEX.CO.,LTD Logo

CRONEX.CO.,LTD

CRO supplying mini-pigs and bio-tissues for non-clinical R&D in medical and cosmetic industries.

215570 | KO

Overview

Corporate Details

ISIN(s):
KR7215570003
LEI:
Country:
South Korea
Address:
경기도 화성시 팔탄면 주석로778번길 55, 화성시
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

CRONEX.CO.,LTD is a Contract Research Organization (CRO) specializing in non-clinical research and development services. Founded in 2012, the company focuses on the production and supply of biological tissue materials and research species, particularly mini-pigs, for pre-clinical studies. Its services cater to the medical, pharmaceutical, and cosmetic industries, offering evaluation testing for applications such as implants, bone repair, and bone regeneration materials. CRONEX utilizes its mini-pig models to assess drug and cosmetic skin penetration and to aid in the development of bio-medical devices. The company's key business divisions include Xenograft and Minipig.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-15 00:00
Capital/Financing Update
[기재정정]주요사항보고서(전환사채권발행결정)
Korean 95.1 KB
2025-05-30 00:00
Report Publication Announcement
기업설명회(IR)개최결과
Korean 6.7 KB
2025-05-13 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.2 KB
2025-03-31 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 19.0 KB
2025-03-21 00:00
Audit Report / Information
감사보고서제출
Korean 10.1 KB
2025-03-21 00:00
Annual Report
사업보고서 (2024.12)
Korean 634.9 KB
2025-03-20 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집공고
Korean 147.3 KB
2025-03-13 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 144.4 KB
2025-02-14 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 10.7 KB
2024-12-23 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2024-12-19 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 57.9 KB
2024-12-18 00:00
Board/Management Information
대표이사변경
Korean 16.7 KB
2024-11-27 00:00
Board/Management Information
대표이사변경
Korean 8.3 KB
2024-10-31 00:00
Regulatory News Service
기업설명회(IR)개최결과
Korean 6.8 KB
2024-10-16 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.2 KB

Automate Your Workflow. Get a real-time feed of all CRONEX.CO.,LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CRONEX.CO.,LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CRONEX.CO.,LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

MicroAd,Inc. Logo
Data-driven marketing tech providing DSP and SSP solutions for digital advertising.
Japan
9553
Microwave Chemical Co., Ltd. Logo
Innovating chemical and metal processing with an eco-friendly microwave platform.
Japan
9227
MindWalk Holdings Corp. Logo
AI-powered biotherapeutics firm offering end-to-end antibody discovery and engineering services.
United States of America
HYFT
Minerva Neurosciences, Inc. Logo
A clinical-stage biopharma developing treatments for central nervous system (CNS) diseases.
United States of America
NERV
A think tank providing research, consulting, and ICT solutions to public & private sectors.
Japan
3636
Modalis Therapeutics Corporation Logo
Develops epigenome editing therapies for genetic muscular, heart, and CNS disorders.
Japan
4883
Model Solution Co., Ltd. Logo
One-stop prototyping & low-volume production for IT, electronics, and medical hardware.
South Korea
417970
Modus Therapeutics Holding AB Logo
Developing sevuparin, a polysaccharide for sepsis, septic shock, and chronic inflammation.
Sweden
MODTX
Moleculin Biotech, Inc. Logo
Developing therapies for hard-to-treat tumors (like AML) and viruses.
United States of America
MBRX
Molecure S.A. Logo
Develops first-in-class small molecule drugs for oncology and inflammatory/fibrotic diseases.
Poland
MOC

Talk to a Data Expert

Have a question? We'll get back to you promptly.